Definium Therapeutics (DFTX) Change in Account Payables (2019 - 2026)
Definium Therapeutics (DFTX) reported Change in Account Payables of $1.8 million for Q1 2026, up 589.92% year-over-year from $258000.0 in Q1 2025, and up 164.35% on a QoQ basis from -$2.8 million in Q4 2025.
Definium Therapeutics (DFTX) has 7 years of Change in Account Payables data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Change in Account Payables rose 589.92% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 243.89% YoY) and the FY2025 annual result came in at $3.3 million, up 256.96% from the prior year.
- Change in Account Payables climbed to $1.8 million in Q1 2026 per DFTX's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.3 million in Q2 2023 and bottomed at -$3.5 million in Q4 2023.
- The 5-year median for Change in Account Payables is $100000.0 (2022), against an average of $174117.6.
- Peak annual rise in Change in Account Payables reached 829.78% in 2025, while the deepest fall reached 1889.93% in 2025.
- Tracing DFTX's Change in Account Payables over 5 years: stood at $1.3 million in 2022, then plunged by 375.73% to -$3.5 million in 2023, then surged by 96.04% to -$139000.0 in 2024, then plunged by 1889.93% to -$2.8 million in 2025, then soared by 164.35% to $1.8 million in 2026.
- Per Business Quant, the three latest DFTX Change in Account Payables figures stand at $1.8 million (Q1 2026), -$2.8 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | 1.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | -2.77 Mn |
| Dec 31, 2025 | -2.77 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 258,000.00 |
| Mar 31, 2025 | 258,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Dec 31, 2024 | -139,000.00 |
| Sep 30, 2024 | -534,000.00 |
| Sep 30, 2024 | -534,000.00 |
| Jun 30, 2024 | -2.96 Mn |
| Jun 30, 2024 | -2.96 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | -3.51 Mn |
| Dec 31, 2023 | -3.51 Mn |
| Sep 30, 2023 | -931,000.00 |
| Sep 30, 2023 | -931,000.00 |
| Jun 30, 2023 | 6.26 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 209,000.00 |
| Mar 31, 2023 | 209,000.00 |
| Dec 31, 2022 | 1.27 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | -2.59 Mn |
| Jun 30, 2022 | -2.59 Mn |
| Mar 31, 2022 | -843,000.00 |
| Mar 31, 2022 | -843,000.00 |
| Dec 31, 2021 | 648,000.00 |
| Dec 31, 2021 | 648,000.00 |
| Sep 30, 2021 | 685,000.00 |
| Sep 30, 2021 | 685,000.00 |
| Jun 30, 2021 | -1.63 Mn |
| Jun 30, 2021 | -1.63 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Mar 31, 2021 | 1.58 Mn |
| Dec 31, 2019 | 1.22 Mn |
| Dec 31, 2019 | 1.22 Mn |